Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.5100 (1.56%) ($22.7400 - $23.6900) on Tue. Jun. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 46 | Latest Price | $23.5100(1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.715% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-14%) TLT(-3%) IYT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
1 - 5 Day Possible Target | $19.34(-17.74%) | Resistance Level | $23.73 | 5 Day Moving Average | $23.16(1.51%) | 10 Day Moving Average | $23.4(0.47%) | 20 Day Moving Average | $23.73(-0.93%) | To recent high | -5.3% | To recent low | 69.1% | Market Cap | $3.213b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |